NIH NIA Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
NIH NIMH Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
NIH NIMH Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
NIH NIMH Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
NIH NINDS NEI NIA NIAAA NIDA NIMH BRAIN Initiative: Preclinical Proof of Concept for Novel Recording and Modulation Technologies in the Human CNS (R18 - Clinical Trial Not Allowed)
NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
Le programme Systèmes alimentaires, microbiomes et santé (PEPR SAMS) (co-piloté par l?Inserm et financé par France 2030) Appels à projet sur Microbiomes, alimentation et santé
ANR EP PerMed - Appel à projets en Recherche, Innovation et Technologie (RITC) 2026 - Test et Démonstration de l?Utilisation de Données Multimodales pour la Médecine Personnalisée (MultiPMData2026)
NIH NINDS NEI NIA NIAAA NIDA NIMH Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
NIH NIDA Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
NIH NIDA Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
NIH NIMH NEI NIA NIAAA NIDCD NIDA NINDS BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)